ENSGALG00000000681 | PAK1 / p21 (RAC1) activated kinase 1 / Q13153* / Mus musculus p21 protein (Cdc42/Rac)-activated kinase 1 (Pak1), transcript variant 3, mRNA.* | / complex / reaction |
ENSGALG00000001264 | PLXNA2 / plexin A2 / O75051* / P70207* | / reaction / complex |
ENSGALG00000002447 | CTNNA1 / catenin alpha 1 / P26231* / P35221* | / reaction |
ENSGALG00000003855 | SRC / P00523 / Proto-oncogene tyrosine-protein kinase Src / P12931* / P05480* / Neuronal proto-onco tyrosine-protein kinase Src * / SRC proto-oncogene, non-receptor tyrosine kinase* | / complex / reaction |
ENSGALG00000004741 | EPHB2 / EPH receptor B2 / P29323* / P54763* / Ephrin type-B receptor 2 * | / complex / reaction |
ENSGALG00000008340 | FES / FES proto-oncogene, tyrosine kinase / P07332* / P16879* / Tyrosine-protein kinase Fes/Fps * | / reaction / complex |
ENSGALG00000008058 | PAK3 / p21 (RAC1) activated kinase 3 / O75914* / Q61036* / Serine/threonine-protein kinase PAK 3 * | / reaction |
ENSGALG00000007130 | RAC1 / Rac family small GTPase 1 / P63000* / P63001* / RAS-related C3 botulinum substrate 1* | / complex / reaction |
ENSGALG00000006109 | MAPK8 / mitogen-activated protein kinase 8 / P45983* / Q91Y86* | / reaction |
ENSGALG00000006609 | EPHB1 / EPH receptor B1 / P54762* / Q8CBF3* / Ephrin type-B receptor 1 * | / complex / reaction |
ENSGALG00000006426 | PAK2 / p21 (RAC1) activated kinase 2 / Q13177* / Q8CIN4* / Serine/threonine-protein kinase PAK 2 PAK-2p27 PAK-2p34* | / reaction |
ENSGALG00000004998 | RAF1 / P05625 / RAF proto-oncogene serine/threonine-protein kinase / Q99N57* / P04049* / Raf-1 proto-oncogene, serine/threonine kinase* / Mus musculus v-raf-leukemia viral onco 1 (Raf1), t... | / reaction |
ENSGALG00000004796 | CDC42 / Q90694 / Cell division control protein 42 homolog / P60766* / P60953* / cell division cycle 42* / Cell division control * | / complex / reaction |
ENSGALG00000006097 | PLXNA1 / plexin A1 / P70206* / Q9UIW2* | / reaction / complex |
ENSGALG00000015022 | FYN / tyrosine-protein kinase Fyn / P06241* / P39688* / FYN proto-oncogene, Src family tyrosine kinase* | / complex / reaction |
ENSGALG00000017414 | JUP / junction plakoglobin / P14923* / Q02257* | / reaction |
ENSGALG00000008073 | NF2 / neurofibromin 2 / P35240* / P46662* / Merlin * | / complex / reaction |
ENSGALG00000029175 | EFNB2 / ephrin B2 / P52799* / P52800* | / complex / reaction |
ENSGALG00000001076 | LIMK1 / Q8QFP8 / LIM domain kinase 1 / P53667* / P53668* | / reaction |
ENSGALG00000023703 | GIT1 / GIT ArfGAP 1 / Q68FF6* / Q9Y2X7* / ARF GTPase-activating protein GIT1 * | / complex / reaction |
ENSGALG00000029260 | H-RAS / P08642 / GTPase HRas GTPase HRas, N-terminally processed / HRAS* / Q61411* / P01112* / HRas proto-oncogene, GTPase* | / reaction |
ENSGALG00000032349 | CDH5 / Q8AYD0 / Cadherin-5 / P33151* / P55284* | / reaction |
ENSGALG00000030943 | KRAS / KRAS proto-oncogene, GTPase / P01116* / P32883* / GTPase KRas GTPase KRas, N-terminally processed* | / reaction |
ENSGALG00000031448 | MAPK6 / Q5F3W3 / Mitogen-activated protein kinase 6 / Q16659* / Q61532* | / reaction |
ENSGALG00000039327 | VAV3 / vav guanine nucleotide exchange factor 3 / Q9R0C8* / Q9UKW4* / vav 3 oncogene* | / complex / reaction |
ENSGALG00000002113 | LCP2 / lymphocyte cytosolic protein 2 / Q13094* / Q60787* | / complex / reaction |
ENSGALG00000003750 | PLCG1 / phospholipase C gamma 1 / P19174* / Q62077* / 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 * | / complex / reaction |
ENSGALG00000008016 | GRB2 / growth factor receptor-bound protein 2 / P62993* / Q60631* | / complex / reaction |
ENSGALG00000033507 | PLCG2 / phospholipase C gamma 2 / P16885* / Q8CIH5* / 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 * | / complex / reaction |
ENSGALG00000039775 | SHC1 / SHC adaptor protein 1 / P29353* / P98083* / SHC-transforming protein 1 * | / complex / reaction |
ENSGALG00000039450 | SOS1 / SOS Ras/Rac guanine nucleotide exchange factor 1 / Q07889* / Q62245* / Son of sevenless homolog 1 * | / complex / reaction |